This clinical trial tests how well a breast CT scan works to improve lesion detection for women undergoing breast screening. The breast CT device takes multiple pictures of the breast and creates a 3-D image of the breast. This may help doctors to see the small structures in breast tissue more clearly and may give a more accurate diagnosis of cancer. This is important because 25% to 35% of structures that do not appear to be normal and are removed (biopsied) for studying under a microscope turn out to be cancer.
Additional locations may be listed on ClinicalTrials.gov for NCT03954431.
Locations matching your search criteria
United States
Arizona
Tucson
Banner University Medical Center - TucsonStatus: Approved
Contact: Srinivasan Vedantham
PRIMARY OBJECTIVE:
I. To determine if, at mean glandular radiation dose (MGD) suitable for screening, dedicated breast computed tomography (CT) (BCT) without intravenously administered contrast media (i.e., non-contrast scans) will improve lesion detection and diagnosis compared to the standard 2-view digital breast tomosynthesis (DBT) with synthesized mammography (SM).
OUTLINE:
Patients undergo bilateral breast CT scan, over approximately 10 seconds for each breast, for a total of less than 5 minutes. If a lesion or additional findings are identified, patients may also undergo standard of care ultrasound, magnetic resonance imaging (MRI) and/or biopsy.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationBanner University Medical Center - Tucson
Principal InvestigatorSrinivasan Vedantham
